TILDRAKIZUMAB

UNII: DEW6X41BEK
Preferred Substance Name: TILDRAKIZUMAB

1326244-10-3
ILUMYA
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS IL23A (INTERLEUKIN 23 ALPHA SUBUNIT (P19), IL-23A)), HUMANIZED MONOCLONAL ANTIBODY
MK-3222
SCH-900222
TILDRAKIZUMAB [INN]
TILDRAKIZUMAB [JAN]
TILDRAKIZUMAB [MI]
TILDRAKIZUMAB [USAN]
TILDRAKIZUMAB [WHO-DD]
TILDRAKIZUMAB ASMN [WHO-DD]
TILDRAKIZUMAB, LICENSE HOLDER UNSPECIFIED
TILDRAKIZUMAB-ASMN
TILDRAKIZUMAB-ASMN [PURPLE BOOK CDER]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TILDRAKIZUMAB

Synonyms and Mappings

Resources

Note